Holpro vision Report issue

Academic/Hospital Phase 4
Founded: Union KY United States

Organization Overview

First Clinical Trial
2014
NCT02028312
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (3)

cyclosporine (sandimmune) (1 trial)

loteprednol (lotemax) (1 trial)

methylcellulose (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dry Eye Syndromes (Phase 4)

Eye Diseases (Phase 4)

Keratoconjunctivitis Sicca (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 3